Neuropathic pain in diabetes. Other chronic pain
Conditions
Interventions
Intervention 1: Intervention group 1: Primary motor cortical anodic tDCS group of the brain (M1)
the group receives 12 sessions, 3 days a week
each session will last 40 minutes (20 minutes left M1 stimulation and 20 minutes right M1 stimulation) in that patients will receive transcranial direct current stimulation (tDCS) for the M1 region wi
this group receives 12 sessions, 3 days a week. Therr will be 20 minutes of M1 anodic tDCS (10 minutes left M1 stimulation and 10 minutes of right M1 stimulation) and 20 minutes of F3 region anodic tD
for this group, the tDCS device, equipped with the default settings for sham stimulation, will provide real stimulation for 20 seconds, then despite remaining of the anode pad on M1 region for 20 minu
Sponsors
Payam-e-Noor University
Eligibility
Sex/Gender
All
Age
30 Years to 55 Years
Inclusion criteria
Inclusion criteria: Having at least 3 year history of diabetes Having neuropathic pain Not receiving psychological treatment since the diagnosis Having at least middle school education Being right-handed
Exclusion criteria
Exclusion criteria: Acute psychological illness Having a pacemaker or intracardiac defibrillator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score on the McGill Pain Scale. Timepoint: Measurement of pain at the beginning of the study (before the intervention), immediately after the last intervention session, 30 days after the intervention. Method of measurement: the McGill Pain Scale.;HB A1c. Timepoint: Measurement of HB a1c before the study (last test in two-three months before the intervention), immediately after the last intervention session, 3 months after the intervention. Method of measurement: blood test.;Glucagon. Timepoint: Measurement of pain at the beginning of the study (before the intervention), immediately after the last intervention session, 30 days after the intervention. Method of measurement: blood test.;Insulin. Timepoint: Measurement of pain at the beginning of the study (before the intervention), immediately after the last intervention session, 30 days after the intervention. Method of measurement: blood test.;Cortisol. Timepoint: Measurement of pain at the beginning of the study (before the intervention), immediately after the last intervention session, 30 days after the intervention. Method of measurement: blood test.;Metanephrine. Timepoint: Measurement of pain at the beginning of the study (before the intervention), immediately after the last intervention session, 30 days after the intervention. Method of measurement: blood test.;Normetanephrine. Timepoint: Measurement of pain at the beginning of the study (before the intervention), immediately after the last intervention session, 30 days after the intervention. Method of measurement: blood test.;White cell count. Timepoint: Measurement of pain at the beginning of the study (before the intervention), immediately after the last intervention session, 30 days after the intervention. Method of measurement: blood test.;Red blood cell count. Timepoint: Measurement of pain at the beginning of the study (before the intervention), immediately after the last intervention session, 30 days after the intervention. Method of measurement: | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRogayeh mohammadi
PayameNoor university
Outcome results
None listed